Cardioprotection by gene therapy

A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology

Rosalinda Madonna, Christian Cadeddu, Martino Deidda, Z. Giricz, Clelia Madeddu, Donato Mele, Ines Monte, Giuseppina Novo, Pasquale Pagliaro, Alessia Pepe, Paolo Spallarossa, Carlo Gabriele Tocchetti, Zoltán V. Varga, Concetta Zito, Yong Jian Geng, Giuseppe Mercuro, P. Ferdinándy

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Ischemic heart disease remains the leading cause of death worldwide. Ischemic pre-, post-, and remote conditionings trigger endogenous cardioprotection that renders the heart resistant to ischemic-reperfusion injury (IRI). Mimicking endogenous cardioprotection by modulating genes involved in cardioprotective signal transduction provides an opportunity to reproduce endogenous cardioprotection with better possibilities of translation into the clinical setting. Genes and signaling pathways by which conditioning maneuvers exert their effects on the heart are partially understood. This is due to the targeted approach that allowed identifying one or a few genes associated with IRI and cardioprotection. Genes critical for signaling pathways in cardioprotection include protectomiRs (e.g., microRNA 125b∗), ZAC1 transcription factor, pro-inflammatory genes such as cycloxygenase (COX)-2 and inducible nitric oxide synthase (iNOS), antioxidant enzymes such as hemoxygenase (HO)-1, extracellular and manganese superoxidase dismutases (ec-SOD and Mg-SOD), heat shock proteins (HSPs), growth factors such as insulin like growth factor (IGF)-1 and hepatocyte growth factor (HGF), antiapoptotic proteins such as Bcl-2 and Bcl-xL, pro-apoptotic proteins such as FasL, Bcl-2, Bax, caspase-3 and p53, and proangiogenic genes such as TGFbeta, sphingosine kinase 1 (SPK1), and PI3K-Akt. By identifying the gene expression profiles of IRI and ischemic conditioning, one may reveal potential gene targets responsible for cardioprotection. In this manuscript, we review the current state of the art of gene therapy in cardioprotection and propose that gene expression analysis facilitates the identification of individual genes associated with cardioprotection. We discuss signaling pathways associated with cardioprotection that can be targeted by gene therapy to achieve cardioprotection.

Original languageEnglish
Pages (from-to)203-210
Number of pages8
JournalInternational Journal of Cardiology
Volume191
DOIs
Publication statusPublished - Jul 15 2015

Fingerprint

Cardiology
Genetic Therapy
Pharmaceutical Preparations
Genes
Reperfusion Injury
Art Therapy
Apoptosis Regulatory Proteins
Critical Pathways
Hepatocyte Growth Factor
p53 Genes
Somatomedins
Nitric Oxide Synthase Type II
Manganese
Heat-Shock Proteins
Cardiotoxicity
MicroRNAs
Phosphatidylinositol 3-Kinases
Transcriptome
Caspase 3
Transforming Growth Factor beta

Keywords

  • Cardioprotection
  • Gene therapy
  • Genomics
  • Ischemic heart disease
  • Postconditioning
  • Preconditioning
  • Remote conditioning

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cardioprotection by gene therapy : A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology. / Madonna, Rosalinda; Cadeddu, Christian; Deidda, Martino; Giricz, Z.; Madeddu, Clelia; Mele, Donato; Monte, Ines; Novo, Giuseppina; Pagliaro, Pasquale; Pepe, Alessia; Spallarossa, Paolo; Tocchetti, Carlo Gabriele; Varga, Zoltán V.; Zito, Concetta; Geng, Yong Jian; Mercuro, Giuseppe; Ferdinándy, P.

In: International Journal of Cardiology, Vol. 191, 15.07.2015, p. 203-210.

Research output: Contribution to journalArticle

Madonna, R, Cadeddu, C, Deidda, M, Giricz, Z, Madeddu, C, Mele, D, Monte, I, Novo, G, Pagliaro, P, Pepe, A, Spallarossa, P, Tocchetti, CG, Varga, ZV, Zito, C, Geng, YJ, Mercuro, G & Ferdinándy, P 2015, 'Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology', International Journal of Cardiology, vol. 191, pp. 203-210. https://doi.org/10.1016/j.ijcard.2015.04.232
Madonna, Rosalinda ; Cadeddu, Christian ; Deidda, Martino ; Giricz, Z. ; Madeddu, Clelia ; Mele, Donato ; Monte, Ines ; Novo, Giuseppina ; Pagliaro, Pasquale ; Pepe, Alessia ; Spallarossa, Paolo ; Tocchetti, Carlo Gabriele ; Varga, Zoltán V. ; Zito, Concetta ; Geng, Yong Jian ; Mercuro, Giuseppe ; Ferdinándy, P. / Cardioprotection by gene therapy : A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology. In: International Journal of Cardiology. 2015 ; Vol. 191. pp. 203-210.
@article{6360843b22c246d8bdf75a730fb35ebe,
title = "Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology",
abstract = "Ischemic heart disease remains the leading cause of death worldwide. Ischemic pre-, post-, and remote conditionings trigger endogenous cardioprotection that renders the heart resistant to ischemic-reperfusion injury (IRI). Mimicking endogenous cardioprotection by modulating genes involved in cardioprotective signal transduction provides an opportunity to reproduce endogenous cardioprotection with better possibilities of translation into the clinical setting. Genes and signaling pathways by which conditioning maneuvers exert their effects on the heart are partially understood. This is due to the targeted approach that allowed identifying one or a few genes associated with IRI and cardioprotection. Genes critical for signaling pathways in cardioprotection include protectomiRs (e.g., microRNA 125b∗), ZAC1 transcription factor, pro-inflammatory genes such as cycloxygenase (COX)-2 and inducible nitric oxide synthase (iNOS), antioxidant enzymes such as hemoxygenase (HO)-1, extracellular and manganese superoxidase dismutases (ec-SOD and Mg-SOD), heat shock proteins (HSPs), growth factors such as insulin like growth factor (IGF)-1 and hepatocyte growth factor (HGF), antiapoptotic proteins such as Bcl-2 and Bcl-xL, pro-apoptotic proteins such as FasL, Bcl-2, Bax, caspase-3 and p53, and proangiogenic genes such as TGFbeta, sphingosine kinase 1 (SPK1), and PI3K-Akt. By identifying the gene expression profiles of IRI and ischemic conditioning, one may reveal potential gene targets responsible for cardioprotection. In this manuscript, we review the current state of the art of gene therapy in cardioprotection and propose that gene expression analysis facilitates the identification of individual genes associated with cardioprotection. We discuss signaling pathways associated with cardioprotection that can be targeted by gene therapy to achieve cardioprotection.",
keywords = "Cardioprotection, Gene therapy, Genomics, Ischemic heart disease, Postconditioning, Preconditioning, Remote conditioning",
author = "Rosalinda Madonna and Christian Cadeddu and Martino Deidda and Z. Giricz and Clelia Madeddu and Donato Mele and Ines Monte and Giuseppina Novo and Pasquale Pagliaro and Alessia Pepe and Paolo Spallarossa and Tocchetti, {Carlo Gabriele} and Varga, {Zolt{\'a}n V.} and Concetta Zito and Geng, {Yong Jian} and Giuseppe Mercuro and P. Ferdin{\'a}ndy",
year = "2015",
month = "7",
day = "15",
doi = "10.1016/j.ijcard.2015.04.232",
language = "English",
volume = "191",
pages = "203--210",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Cardioprotection by gene therapy

T2 - A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology

AU - Madonna, Rosalinda

AU - Cadeddu, Christian

AU - Deidda, Martino

AU - Giricz, Z.

AU - Madeddu, Clelia

AU - Mele, Donato

AU - Monte, Ines

AU - Novo, Giuseppina

AU - Pagliaro, Pasquale

AU - Pepe, Alessia

AU - Spallarossa, Paolo

AU - Tocchetti, Carlo Gabriele

AU - Varga, Zoltán V.

AU - Zito, Concetta

AU - Geng, Yong Jian

AU - Mercuro, Giuseppe

AU - Ferdinándy, P.

PY - 2015/7/15

Y1 - 2015/7/15

N2 - Ischemic heart disease remains the leading cause of death worldwide. Ischemic pre-, post-, and remote conditionings trigger endogenous cardioprotection that renders the heart resistant to ischemic-reperfusion injury (IRI). Mimicking endogenous cardioprotection by modulating genes involved in cardioprotective signal transduction provides an opportunity to reproduce endogenous cardioprotection with better possibilities of translation into the clinical setting. Genes and signaling pathways by which conditioning maneuvers exert their effects on the heart are partially understood. This is due to the targeted approach that allowed identifying one or a few genes associated with IRI and cardioprotection. Genes critical for signaling pathways in cardioprotection include protectomiRs (e.g., microRNA 125b∗), ZAC1 transcription factor, pro-inflammatory genes such as cycloxygenase (COX)-2 and inducible nitric oxide synthase (iNOS), antioxidant enzymes such as hemoxygenase (HO)-1, extracellular and manganese superoxidase dismutases (ec-SOD and Mg-SOD), heat shock proteins (HSPs), growth factors such as insulin like growth factor (IGF)-1 and hepatocyte growth factor (HGF), antiapoptotic proteins such as Bcl-2 and Bcl-xL, pro-apoptotic proteins such as FasL, Bcl-2, Bax, caspase-3 and p53, and proangiogenic genes such as TGFbeta, sphingosine kinase 1 (SPK1), and PI3K-Akt. By identifying the gene expression profiles of IRI and ischemic conditioning, one may reveal potential gene targets responsible for cardioprotection. In this manuscript, we review the current state of the art of gene therapy in cardioprotection and propose that gene expression analysis facilitates the identification of individual genes associated with cardioprotection. We discuss signaling pathways associated with cardioprotection that can be targeted by gene therapy to achieve cardioprotection.

AB - Ischemic heart disease remains the leading cause of death worldwide. Ischemic pre-, post-, and remote conditionings trigger endogenous cardioprotection that renders the heart resistant to ischemic-reperfusion injury (IRI). Mimicking endogenous cardioprotection by modulating genes involved in cardioprotective signal transduction provides an opportunity to reproduce endogenous cardioprotection with better possibilities of translation into the clinical setting. Genes and signaling pathways by which conditioning maneuvers exert their effects on the heart are partially understood. This is due to the targeted approach that allowed identifying one or a few genes associated with IRI and cardioprotection. Genes critical for signaling pathways in cardioprotection include protectomiRs (e.g., microRNA 125b∗), ZAC1 transcription factor, pro-inflammatory genes such as cycloxygenase (COX)-2 and inducible nitric oxide synthase (iNOS), antioxidant enzymes such as hemoxygenase (HO)-1, extracellular and manganese superoxidase dismutases (ec-SOD and Mg-SOD), heat shock proteins (HSPs), growth factors such as insulin like growth factor (IGF)-1 and hepatocyte growth factor (HGF), antiapoptotic proteins such as Bcl-2 and Bcl-xL, pro-apoptotic proteins such as FasL, Bcl-2, Bax, caspase-3 and p53, and proangiogenic genes such as TGFbeta, sphingosine kinase 1 (SPK1), and PI3K-Akt. By identifying the gene expression profiles of IRI and ischemic conditioning, one may reveal potential gene targets responsible for cardioprotection. In this manuscript, we review the current state of the art of gene therapy in cardioprotection and propose that gene expression analysis facilitates the identification of individual genes associated with cardioprotection. We discuss signaling pathways associated with cardioprotection that can be targeted by gene therapy to achieve cardioprotection.

KW - Cardioprotection

KW - Gene therapy

KW - Genomics

KW - Ischemic heart disease

KW - Postconditioning

KW - Preconditioning

KW - Remote conditioning

UR - http://www.scopus.com/inward/record.url?scp=84940924976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940924976&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2015.04.232

DO - 10.1016/j.ijcard.2015.04.232

M3 - Article

VL - 191

SP - 203

EP - 210

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -